2015 American Transplant Congress
Epstein Barr Virus Modulates Host Cell MicroRNA-194 to Promote IL-10 Production in B Cell Lymphomas
Surgery/Division of Abdominal Transplant, Stanford University School of Medicine, Stanford, CA.
Epstein Barr virus (EBV) infection is associated with the development of post-transplant lymphoproliferative disorder (PTLD) which can manifest as aggressive B cell lymphomas in transplant…2015 American Transplant Congress
Post-Transplant Lymphoproliferative Disorders Following Alemtuzumab Induction in Kidney Transplantation
Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, England, United Kingdom.
Post-Transplant Lymphoproliferative Disorder (PLTD) is a well-recognised serious complication in renal transplant recipients. Induction with lymphocyte depleting agents such as thymoglobulin has been associated with…2015 American Transplant Congress
B Cell MicroRNA as Biomarkers for Epstein-Barr Virus Associated Post-Transplant Lymphoproliferative Disorder
Surgery/Division of Abdominal Transplant, Stanford University School of Medicine, Stanford, CA.
Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication of organ transplantation and is commonly associated with Epstein Barr virus (EBV) infection. EBV viral loads…2015 American Transplant Congress
Elevated Cancer Risk Among US Pediatric Solid Organ Transplant Recipients
Among pediatric transplant recipients, the effects of transplantation and immunosuppression on cancer risk may be unique from those observed in the adult transplant population. No…2015 American Transplant Congress
Hospital Re-Admission After Intestinal Transplantation
Aim. Intestinal transplant (ITx) recipients frequently require repeat hospital admissions after successful transplant, increasing costs and causing significant burden on families. The causes of hospital…2015 American Transplant Congress
Reciprocal Relationship Between Cytomegalovirus Infection and Graft Rejection in Intestinal/Multivisceral Transplantation: Impact on Survival and Ideal Immunosuppression Protocol
Transplant Surgery, Indiana University School of Medicine, Indianapolis, IN.
Background: Cytomegalovius (CMV) infection and graft rejection are opposing complications of isolated intestinal/multivisceral transplantation (IIT/MVT), a procedure requiring precise balance of immunosuppression. The aim of…2015 American Transplant Congress
Incidence, Timing, and Consequence of De Novo Donor Specific Antibody in Intestinal Transplantation
Center for Intestinal Care and Transplant, Medstar Georgetown Transplant Institute, Washington, DC.
The development of denovo Donor specific antibody (dnDSA) in intestinal transplantation (ITx) remains largely unknown. We conducted a prospective and longitudinal analysis of adult and…2015 American Transplant Congress
Vascularised Composite Allografts and Intestinal Transplantation: Does the Skin Component Provide a Pre-Rejection Marker for the Visceral Organ?
Oxford Transplant Centre, Oxford University Hospitals, Oxford, United Kingdom.
Introduction: Can the skin component of a synchronously transplanted vascularised composite allograft (VCA) be used as a pre-rejection marker for the intestinal transplant (IT)?Methods: Recipients…2015 American Transplant Congress
Surgical Site Infections After Intestinal and Multivisceral Transplantation
Transplant Institute, MedStar Georgetown University Hospital, Washington, DC.
Aim:Intestinal transplant (ITx) recipients harbor risk factors implicated in surgical site infections (SSI): multiple prior abdominal surgeries, complex operative course, grafts with significant microbial load,…2015 American Transplant Congress
Multivisceral Transplantation Without an Ostomy – Experience With 15 Patients
Miami Transplant Institute, University of Miami Miller School of Medicine, Miami, FL.
Introduction: Despite improvement in short term outcomes, rejection remains a main cause of graft and patient loss in intestinal transplant. A temporary ostomy to assess…